Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity

BACKGROUND/AIMS: Thiopurines are key drugs for inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). Recently, NUDT15 polymorphism (R139C, c.415C > T) has been shown to be associated with thiopurine-induced adverse events in Asian populations. In patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Takato, Sakuraba, Hirotake, Hiraga, Hiroto, Yoshida, Shukuko, Kakuta, Yoichi, Kikuchi, Hidezumi, Kawaguchi, Shogo, Hasui, Keisuke, Tatsuta, Tetsuya, Chinda, Daisuke, Mikami, Tatsuya, Fukuda, Shinsaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831774/
https://www.ncbi.nlm.nih.gov/pubmed/33472343
http://dx.doi.org/10.5217/ir.2020.00133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831774/
https://www.ncbi.nlm.nih.gov/pubmed/33472343
http://dx.doi.org/10.5217/ir.2020.00133

Ejemplares similares